Table: begin end state 1 26 cytoplasmic 27 47 transmembrane 48 53 non-cytoplasmic 54 73 transmembrane 74 106 cytoplasmic 107 129 transmembrane 130 134 non-cytoplasmic 135 153 transmembrane 154 163 cytoplasmic 164 187 transmembrane 188 207 non-cytoplasmic 208 230 transmembrane 231 249 cytoplasmic 250 270 transmembrane 271 290 non-cytoplasmic 291 313 transmembrane 314 344 cytoplasmic 345 362 transmembrane 363 367 non-cytoplasmic 368 389 transmembrane 390 409 cytoplasmic 410 432 transmembrane 433 437 non-cytoplasmic 438 457 transmembrane 458 473 cytoplasmic
Input: >Pf6N2E2_5459 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_5459 MAVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA VAVYMGIWFPDVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVIGGVG IIAFGFGNDGVALGISNLWTHGGFMPNGVQGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFATTSANGVPRRALLLSIAALLLGVLLN YLVPEKVFVWVTSIATFGAIWTWVMILLAQLKFRKSLSASERAALKYRMWLYPVSSYLAL AFLVLVVGLMAYFPDTRVALYVGPAFLVLLTVLFYVFKLQPTGETHGSVRSVS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server